Allergic rhinitis

American Journal of Rhinology and Allergy

Volumn 27, Issue SUPPL.1, 2013, Pages

  Settipane, Russell A ^a   Schwindt, Christina ^b  

^a BROWN UNIVERSITY   (United States)

^b Allergy & Asthma Associates of Northern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BROMPHENIRAMINE; CARBINOXAMINE MALEATE; CETIRIZINE; CHLORPHENIRAMINE; CICLESONIDE; CLEMASTINE; CORTICOSTEROID; DECONGESTIVE AGENT; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; LEVOCETIRIZINE; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; OLOPATADINE; OXYMETAZOLINE; PHENYLEPHRINE; PSEUDOEPHEDRINE; TRIAMCINOLONE ACETONIDE; TRIPROLIDINE; UNINDEXED DRUG; ZAFIRLUKAST; AUTACOID; IMMUNOGLOBULIN E;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; BASOPHIL; CELL PROLIFERATION; CORTICOSTEROID THERAPY; EOSINOPHIL; HUMAN; NOSE POLYP; OTITIS MEDIA; PATHOPHYSIOLOGY; QUALITY OF LIFE; SINUSITIS; T LYMPHOCYTE; TH2 CELL; DESENSITIZATION; IMMUNOLOGY; NOSE MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEROLOGY; SKIN TEST;

ADRENAL CORTEX HORMONES; DESENSITIZATION, IMMUNOLOGIC; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEROLOGIC TESTS; SKIN TESTS;

EID: 84893366294     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3928     Document Type: Article

References (49)

1. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122:S1-S84, 2008.
2. Settipane RA, and Kaliner MA. Nonallergic rhinitis. Am J Rhinol Allergy 27:S48-S51, 2013.
3. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63 (suppl):8-160, 2008.
4. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 19:23-34, 2007.
5. Katelaris CH, Lai CK, Rhee CS, et al. Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific Survey. Am J Rhinol Allergy 25 Suppl 1:S3-15, 2011.
6. Bernstein JA. Allergic and mixed rhinitis: Epidemiology and natural history. Allergy Asthma Proc 31:365-369, 2010.
7. Meltzer EO, Blaiss MS, Naclerio RM, et al. Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc 33(suppl 1):S113-S141, 2012.
8. Abdulrahman H, Hadi U, Tarraf H, et al. Nasal allergies in the Middle Eastern population: Results from the "Allergies in Middle East Survey." Am J Rhinol Allergy 26(suppl 1):S3-S23, 2012.
9. Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 20:209-213, 1999.
10. Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy 26:120-122, 2012.
11. de la Hoz Caballer B, Rodríguez M, Fraj J, et al. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: The Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy 26:390-394, 2012.
12. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 31:375-380, 2010.
13. Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc 31:370-374, 2010.
14. Coombs RRA, and Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In Clinical Aspect of Immunology, 3rd ed. Gell PGH, Coombs RRA, and Lachman PJ (Eds). Oxford, U.K.: Blackwell Scientific Publications, 575-596, 1975.
15. Uzzaman A, and Cho SH. Classification of hypersensitivity reactions. Allergy Asthma Proc 33(suppl 1):S96-S99, 2012.
16. Shah R, and Grammer LC. An overview of allergens. Allergy Asthma Proc 33(suppl 1):S2-S5, 2012.
17. Luccioli S, Escobar-Gutierrez A, Bellanti JA. Allergic diseases and asthma. In Immunology IV: Clinical applications in heath and disease. Bethesda: I Care, 685-765, 2012.
18. Connell JT. Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy 43:33-44, 1969.
19. Rondón C, Campo P, Galindo L, et al. Prevalence and clinical relevance of local allergic rhinitis. Allergy 67:1282-1288, 2012.
20. Carr TF, and Saltoun CA. Skin testing in allergy. Allergy Asthma Proc 33(suppl 1):S6-S8, 2012.
21. Settipane RA, Borish L, and Peters AT. Determining the role of allergy in sinonasal disease. Am J Rhinol Allergy 27:S56-S58, 2013.
22. Canbaz P, Uskudar-Teke H, Aksu K, et al. Nasal eosinophilia can predict bronchial hyperresponsiveness in persistent rhinitis: Evidence for united airways disease concept. Am J Rhinol Allergy 25: 120-124, 2011.
23. Bukstein D, Luskin AT, and Farrar Jr. The reality of adherence to rhinitis treatment: Identifying and overcoming the barriers. Allergy Asthma Proc 32:265-271, 2011.
24. Blaiss MS. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 32:413-418, 2011.
25. van Bavel JH, Ratner PH, Amar NJ, et al. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis. Allergy Asthma Proc 33:386-396, 2012.
26. Meltzer EO, Jacobs RL, LaForce CF, et al. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Allergy Asthma Proc 33:249-257, 2012.
27. Berger WE, Mohar DE, LaForce C, et al. A 26-week tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis. Am J Rhinol Allergy 26:302-307, 2012.
28. Ratner PH, Andrews C, Martin B, et al. A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen. Allergy Asthma Proc 33:27-35, 2012.
29. Mohar D, Berger WE, Laforce C, et al. Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis. Allergy Asthma Proc 33:19-26, 2012.
30. Han D, Liu S, Zhang Y, et al. Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis. Allergy Asthma Proc 32:472-481, 2011.
31. Fokkens WJ, Rinia B, van Drunen CM, et al. No mucosal atrophy and reduced inflammatory cells: Active-controlled trial with yearlong fluticasone furoate nasal spray. Am J Rhinol Allergy 26:36-44, 2012.
32. Yamada T, Yamamoto H, Kubo S, et al. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitisdisturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc 33:e9-e16, 2012.
33. Lieberman P, Meltzer EO, LaForce CF, et al. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. Allergy Asthma Proc 32:151-158, 2011.
34. Meltzer EO, Blaiss M, and Fairchild CJ. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis. Allergy Asthma Proc 32:213-220, 2011.
35. Ciebiada M, Gorska-Ciebiada M, Barylski M, et al. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy 25:e1-e6, 2011.
36. Yamamoto H, Yamada T, Sakashita M, et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc 33:e17-e22, 2012.
37. Fairchild CJ, Durden E, Cao Z, and Smale P. Outcomes and cost comparison of three therapeutic approaches to allergic rhinitis. Am J Rhinol Allergy 25:257-262, 2011.
38. Carr WW, Ratner P, Munzel U, et al. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Allergy Asthma Proc 33:450-458, 2012.
39. Meier EJ, Torkildsen GL, Gow JA, et al. Bepotastine Besilate Ophthalmic Solutions Study Group. Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis. Allergy Asthma Proc 33:265-274, 2012.
40. Baroody FM, Logothetis H, Vishwanath S, et al. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy 27:48-53, 2013.
41. Gilbey P, McGruthers L, Morency AM, and Shrim A. Rhinosinusitisrelated quality of life during pregnancy. Am J Rhinol Allergy 26:283-286, 2012.
42. Hermelingmeier KE, Weber RK, Hellmich M, et al. Nasal irrigation as an adjunctive treatment in allergic rhinitis: A systematic review and meta-analysis. Am J Rhinol Allergy 26:e119-e125, 2012.
43. Meltzer EO, Schatz M, Nathan R, et al. Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis. J Allergy Clin Immunol 131:379-386, 2013.
44. Schatz M, Zeiger RS, Chen W, et al. A comparison of the psychometric properties of the Mini-Rhinitis Quality of Life Questionnaire and the Rhinitis Control Assessment Test. Am J Rhinol Allergy 26:127-133, 2012.
45. Meltzer EO, LaForce C, Ratner P, et al. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, doubleblind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc 33:324-332, 2012.
46. Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol 129:1282-1289.e10, 2012.
47. Georgy MS, and Saltoun CA. Allergen immunotherapy: Definition, indication, and reactions. Allergy Asthma Proc 33(suppl 1): S9-S11, 2012.
48. Uzzaman A, and Story R. Allergic rhinitis. Allergy Asthma Proc 33(suppl 1):S15-S18, 2012.
49. Settipane RA, Peters AT, and Borish L. Immunomodulation of allergic sinonasal disease. Am J Rhinol Allergy 27:S59-S62, 2013.